Discovery and structure-activity relationship studies of novel Bcl-2/Mcl-1 dual inhibitors with indole scaffold

被引:8
作者
Zhang, Zhenwei [1 ]
Hou, Linghui [1 ]
Bai, Lijun [1 ]
Pei, Jiying [1 ]
Zhao, Shan [1 ]
Liu, Dan [1 ]
Luan, Shenglin [2 ]
Huang, Min [1 ]
Zhao, Linxiang [1 ]
机构
[1] Shenyang Pharmaceut Univ, Key Lab Struct Based Drugs Design & Discovery Mini, Shenyang 110016, Peoples R China
[2] China Resources Sanjiu Med & Pharmaceut Co Ltd, Shenzhen, Peoples R China
关键词
Apoptosis; Bcl-2; Mcl-1 dual inhibitor; Anti-tumor; MCL-1; DERIVATIVES; MECHANISM; ABT-199; BINDING; CANCER;
D O I
10.1016/j.bioorg.2022.105845
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Bcl-2 anti-apoptotic proteins were widely overexpressed in diverse tumor cells, especially for Bcl-2 and Mcl1, which regarding as important targets of apoptosis induction and resistance of chemotherapy. We identified novel Bcl-2/Mcl-1 dual inhibitors with indole scaffold by the optimization of hit 1. Structure modification against several moieties including hydrophobic fragment, side chain and benzoic acid fragment was conducted and the structure-activity relationship was analyzed. The representative compound 12f exhibited sub-micromolar binding affinities to Bcl-2/Mcl-1 without binding affinity to Bcl-XL. Mechanism of action studies suggested that compound 12f dose-dependently triggered apoptosis in HL-60 cells. Compound 12f represents a novel Bcl-2/ Mcl-1 dual inhibitor which deserving further study.
引用
收藏
页数:12
相关论文
共 22 条
[1]   Pathways and mechanisms of venetoclax resistance [J].
Bose, Prithviraj ;
Gandhi, Varsha ;
Konopleva, Marina .
LEUKEMIA & LYMPHOMA, 2017, 58 (09) :2026-2039
[2]   Targeting MCL-1 and BCL-2: a 1-2 punch [J].
Brown, Jennifer R. .
BLOOD, 2021, 137 (20) :2711-2712
[3]   Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy [J].
Czabotar, Peter E. ;
Lessene, Guillaume ;
Strasser, Andreas ;
Adams, Jerry M. .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2014, 15 (01) :49-63
[4]   Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies [J].
Delbridge, Alex R. D. ;
Grabow, Stephanie ;
Strasser, Andreas ;
Vaux, David L. .
NATURE REVIEWS CANCER, 2016, 16 (02) :99-109
[5]   Hot-Spots of Mcl-1 Protein [J].
Denis, Camille ;
Santos, Jana Sopkova-de Oliveira ;
Bureau, Ronan ;
Voisin-Chiret, Anne Sophie .
JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (03) :928-943
[6]   Hallmarks of Cancer: The Next Generation [J].
Hanahan, Douglas ;
Weinberg, Robert A. .
CELL, 2011, 144 (05) :646-674
[7]   Mechanism-based pharmacokinetic/pharmacodynamic meta-analysis of navitoclax (ABT-263) induced thrombocytopenia [J].
Kaefer, Aksana ;
Yang, Jianning ;
Noertersheuser, Peter ;
Mensing, Sven ;
Humerickhouse, Rod ;
Awni, Walid ;
Xiong, Hao .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (03) :593-602
[8]   Discovery and Characterization of 2,5-Substituted Benzoic Acid Dual Inhibitors of the Anti-apoptotic Mcl-1 and Bfl-1 Proteins [J].
Kump, Karson J. ;
Miao, Lei ;
Mady, Ahmed S. A. ;
Ansari, Nurul H. ;
Shrestha, Uttar K. ;
Yang, Yuting ;
Pal, Mohan ;
Liao, Chenzhong ;
Perdih, Andrej ;
Abulwerdi, Fardokht A. ;
Chinnaswamy, Krishnapriya ;
Meagher, Jennifer L. ;
Carlson, Jacob M. ;
Khanna, May ;
Stuckey, Jeanne A. ;
Nikolovska-Coleska, Zaneta .
JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (05) :2489-2510
[9]   Design, synthesis and structure-activity relationship studies of morpholino-1H-phenalene derivatives that antagonize Mcl-1/Bcl-2 [J].
Li, Xiangqian ;
Liang, Xiaomeng ;
Song, Ting ;
Su, Pengchen ;
Zhang, Zhichao .
BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (21) :5738-5746
[10]   Discovery and structure-activity relationship studies of N-substituted indole derivatives as novel Mcl-1 inhibitors [J].
Luan, Shenglin ;
Ge, Qj ;
Chen, Yedong ;
Dai, Mingyang ;
Yang, Jinyu ;
Li, Kun ;
Liu, Dan ;
Zhao, Linxiang .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (09) :1943-1948